Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaleb Michaud

Showing results (221-230 of 273) with videos related to

Pageof 28
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 28, 2016
A PROMIS Measure of Neuropathic Pain QualityRobert L Askew, Karon F Cook, Francis J Keefe, et al.
Arthritis Care & Research|November 12, 2019
2019 American College of Rheumatology Recommended Patient-Reported Functional Status Assessment Measures in Rheumatoid ArthritisClaire E H Barber, JoAnn Zell, Jinoos Yazdany, et al.
Seminars in Arthritis and Rheumatism|July 27, 2023
Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing studyTeresa A Simon, Samy Suissa, Maarten Boers, et al.
Annals of the Rheumatic Diseases|May 5, 2010
Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritisBenjamin J Miriovsky, Kaleb Michaud, Geoffrey M Thiele, et al.
ACR Open Rheumatology|June 3, 2025
Prevalence of Frailty and Associated Factors in a US-Wide Cohort of Rheumatic DiseasesKatherine D Wysham, Catherine L A Chang, Namrata Singh, et al.
Arthritis Care & Research|November 12, 2019
2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity MeasuresBryant R England, Benedict K Tiong, Martin J Bergman, et al.
Annals of the Rheumatic Diseases|November 6, 2023
Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studiesTeresa A Simon, Lixian Dong, Samy Suissa, et al.
Arthritis Care & Research|February 1, 2020
ReplyBryant R England, Ted R Mikuls, James R O'Dell, et al.
Arthritis Care & Research|May 19, 2022
Identification of Multimorbidity Patterns in Rheumatoid Arthritis Through Machine LearningBryant R England, Yangyuna Yang, Punyasha Roul, et al.
Seminars in Arthritis and Rheumatism|December 3, 2023
Infection outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing studyTeresa A Simon, Samy Suissa, Mary Lou Skovron, et al.
Pageof 28

Showing results (221-230 of 273) with videos related to

Sort By:
Pageof 28
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 28, 2016
A PROMIS Measure of Neuropathic Pain QualityRobert L Askew, Karon F Cook, Francis J Keefe, et al.
Arthritis Care & Research|November 12, 2019
2019 American College of Rheumatology Recommended Patient-Reported Functional Status Assessment Measures in Rheumatoid ArthritisClaire E H Barber, JoAnn Zell, Jinoos Yazdany, et al.
Seminars in Arthritis and Rheumatism|July 27, 2023
Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing studyTeresa A Simon, Samy Suissa, Maarten Boers, et al.
Annals of the Rheumatic Diseases|May 5, 2010
Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritisBenjamin J Miriovsky, Kaleb Michaud, Geoffrey M Thiele, et al.
ACR Open Rheumatology|June 3, 2025
Prevalence of Frailty and Associated Factors in a US-Wide Cohort of Rheumatic DiseasesKatherine D Wysham, Catherine L A Chang, Namrata Singh, et al.
Arthritis Care & Research|November 12, 2019
2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity MeasuresBryant R England, Benedict K Tiong, Martin J Bergman, et al.
Annals of the Rheumatic Diseases|November 6, 2023
Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studiesTeresa A Simon, Lixian Dong, Samy Suissa, et al.
Arthritis Care & Research|February 1, 2020
ReplyBryant R England, Ted R Mikuls, James R O'Dell, et al.
Arthritis Care & Research|May 19, 2022
Identification of Multimorbidity Patterns in Rheumatoid Arthritis Through Machine LearningBryant R England, Yangyuna Yang, Punyasha Roul, et al.
Seminars in Arthritis and Rheumatism|December 3, 2023
Infection outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing studyTeresa A Simon, Samy Suissa, Mary Lou Skovron, et al.
Pageof 28